Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 5767106, 13 pages
http://dx.doi.org/10.1155/2016/5767106
Review Article

Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?

CNRS, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence MEDALIS, Institut de Biologie Moléculaire et Cellulaire, 67084 Strasbourg, France

Received 4 May 2016; Revised 6 July 2016; Accepted 17 July 2016

Academic Editor: Takashi MaruYama

Copyright © 2016 Matthieu Sawaf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., “Development of autoantibodies before the clinical onset of systemic lupus erythematosus,” The New England Journal of Medicine, vol. 349, no. 16, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Lacotte, H. Dumortier, M. Décossas, J.-P. Briand, and S. Muller, “Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice,” The Journal of Immunology, vol. 184, no. 7, pp. 3937–3945, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Arce, D. G. Jackson, M. A. Gill, L. B. Bennett, J. Banchereau, and V. Pascual, “Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus,” The Journal of Immunology, vol. 167, no. 4, pp. 2361–2369, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Jacobi, M. Odendahl, K. Reiter et al., “Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 48, no. 5, pp. 1332–1342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. C. T. Ravirajan, M. A. Rahman, L. Papadaki et al., “Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis,” European Journal of Immunology, vol. 28, no. 1, pp. 339–350, 1998. View at Google Scholar
  6. A. C. Grammer, R. Slota, R. Fischer et al., “Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions,” The Journal of Clinical Investigation, vol. 112, no. 10, pp. 1506–1520, 2003. View at Google Scholar
  7. C. G. Vinuesa, M. A. Linterman, D. Yu, and I. C. M. MacLennan, “Follicular helper T cells,” Annual Review of Immunology, vol. 34, pp. 335–368, 2016. View at Publisher · View at Google Scholar
  8. S. Crotty, “Follicular helper CD4 T cells (TFH),” Annual Review of Immunology, vol. 29, pp. 621–663, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Fazilleau, L. J. McHeyzer-Williams, H. Rosen, and M. G. McHeyzer-Williams, “The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding,” Nature Immunology, vol. 10, no. 4, pp. 375–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. L. S. K. Walker, A. Gulbranson-Judge, S. Flynn et al., “Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers,” The Journal of Experimental Medicine, vol. 190, no. 8, pp. 1115–1122, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Fillatreau and D. Gray, “T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation,” Journal of Experimental Medicine, vol. 197, no. 2, pp. 195–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. S. Choi, R. Kageyama, D. Eto et al., “ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6,” Immunity, vol. 34, no. 6, pp. 932–946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Liu, X. Chen, B. Zhong et al., “Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development,” Nature, vol. 507, no. 7493, pp. 513–518, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Eddahri, S. Denanglaire, F. Bureau et al., “Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities,” Blood, vol. 113, no. 11, pp. 2426–2433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Schmitt, R. Morita, L. Bourdery et al., “Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12,” Immunity, vol. 31, no. 1, pp. 158–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. S. Ma, S. Suryani, D. T. Avery et al., “Early commitment of naïve human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL-12,” Immunology and Cell Biology, vol. 87, no. 8, pp. 590–600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K.-M. Chavele, E. Merry, and M. R. Ehrenstein, “Circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 production,” Journal of Immunology, vol. 194, no. 6, pp. 2482–2485, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. R. I. Nurieva, Y. Chung, D. Hwang et al., “Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages,” Immunity, vol. 29, no. 1, pp. 138–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Dienz, S. M. Eaton, J. P. Bond et al., “The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells,” The Journal of Experimental Medicine, vol. 206, no. 1, pp. 69–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Spolski and W. J. Leonard, “Interleukin-21: basic biology and implications for cancer and autoimmunity,” Annual Review of Immunology, vol. 26, pp. 57–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. C. Heinrich, I. Behrmann, S. Haan, H. M. Hermanns, G. Müller-Newen, and F. Schaper, “Principles of interleukin (IL)-6-type cytokine signalling and its regulation,” Biochemical Journal, vol. 374, no. 1, pp. 1–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. S. Ma, D. T. Avery, A. Chan et al., “Functional STAT3 deficiency compromises the generation of human T follicular helper cells,” Blood, vol. 119, no. 17, pp. 3997–4008, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Mazerolles, C. Picard, S. Kracker, A. Fischer, and A. Durandy, “Blood CD4+CD45RO+CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency,” The Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 1146–1156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Johnston, A. C. Poholek, D. DiToro et al., “Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation,” Science, vol. 325, no. 5943, pp. 1006–1010, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. I. Nurieva, Y. Chung, G. J. Martinez et al., “Bcl6 mediates the development of T follicular helper cells,” Science, vol. 325, no. 5943, pp. 1001–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Yu, S. Rao, L. M. Tsai et al., “The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment,” Immunity, vol. 31, no. 3, pp. 457–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. B. C. Betz, K. L. Jordan-Williams, C. Wang et al., “Batf coordinates multiple aspects of B and T cell function required for normal antibody responses,” Journal of Experimental Medicine, vol. 207, no. 5, pp. 933–942, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. S. Choi, J. A. Gullicksrud, S. Xing et al., “LEF-1 and TCF-1 orchestrate T(HF) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6,” Nature Immunology, vol. 16, no. 9, pp. 980–990, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Stauss, C. Brunner, F. Berberich-Siebelt, U. E. Ho pken, M. Lipp, and G. Mu ller, “The transcriptional coactivator Bob1 promotes the development of follicular T helper cells via Bcl6,” The EMBO Journal, vol. 35, no. 8, pp. 881–898, 2016. View at Publisher · View at Google Scholar
  30. E. L. Stone, M. Pepper, C. D. Katayama et al., “ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation,” Immunity, vol. 42, no. 2, pp. 239–251, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Kerfoot, G. Yaari, J. R. Patel et al., “Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone,” Immunity, vol. 34, no. 6, pp. 947–960, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Qi, J. L. Cannons, F. Klauschen, P. L. Schwartzberg, and R. N. Germain, “SAP-controlled T-B cell interactions underlie germinal centre formation,” Nature, vol. 455, no. 7214, pp. 764–769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. S. Ma, N. J. Hare, K. E. Nichols et al., “Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells,” Journal of Clinical Investigation, vol. 115, no. 4, pp. 1049–1059, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. L. V. Riella, A. M. Paterson, A. H. Sharpe, and A. Chandraker, “Role of the PD-1 pathway in the immune response,” American Journal of Transplantation, vol. 12, no. 10, pp. 2575–2587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. L. Rankin, H. MacLeod, S. Keegan et al., “IL-21 receptor is critical for the development of memory B cell responses,” Journal of Immunology, vol. 186, no. 2, pp. 667–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Ou, S. Xu, and K.-P. Lam, “Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 38, pp. 15401–15406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Goenka, A. H. Matthews, B. Zhang et al., “Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation,” The Journal of Experimental Medicine, vol. 211, no. 1, pp. 45–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Hams, M. J. McCarron, S. Amu et al., “Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells,” The Journal of Immunology, vol. 186, no. 10, pp. 5648–5655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Kashiwakuma, A. Suto, Y. Hiramatsu et al., “B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses,” The Journal of Immunology, vol. 185, no. 5, pp. 2730–2736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Linterman, W. Pierson, S. K. Lee et al., “Foxp3+ follicular regulatory T cells control the germinal center response,” Nature Medicine, vol. 17, no. 8, pp. 975–982, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Chung, S. Tanaka, F. Chu et al., “Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions,” Nature Medicine, vol. 17, no. 8, pp. 983–988, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. G. Kang, W.-H. Liu, P. Lu et al., “MicroRNAs of the miR-17∼92 family are critical regulators of TFH differentiation,” Nature Immunology, vol. 14, no. 8, pp. 849–857, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Baumjohann, R. Kageyama, J. M. Clingan et al., “The microRNA cluster miR-17∼92 promotes TFH cell differentiation and represses subset-inappropriate gene expression,” Nature Immunology, vol. 14, no. 8, pp. 840–848, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Takahashi, T. Kanno, S. Nakayamada et al., “TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells,” Nature Immunology, vol. 13, no. 6, pp. 587–595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Pratama, M. Srivastava, N. J. Williams et al., “MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres,” Nature Communications, vol. 6, article 6436, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Ballesteros-Tato, B. León, B. A. Graf et al., “Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation,” Immunity, vol. 36, no. 5, pp. 847–856, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. R. J. Johnston, Y. S. Choi, J. A. Diamond, J. A. Yang, and S. Crotty, “STAT5 is a potent negative regulator of TFH cell differentiation,” Journal of Experimental Medicine, vol. 209, no. 2, pp. 243–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. R. I. Nurieva, A. Podd, Y. Chen et al., “STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function,” The Journal of Biological Chemistry, vol. 287, no. 14, pp. 11234–11239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. K. J. Oestreich, S. E. Mohn, and A. S. Weinmann, “Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile,” Nature Immunology, vol. 13, no. 4, pp. 405–411, 2012. View at Publisher · View at Google Scholar
  50. C. G. Vinuesa, M. C. Cook, C. Angelucci et al., “A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity,” Nature, vol. 435, no. 7041, pp. 452–458, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. M. A. Linterman, R. J. Rigby, R. K. Wong et al., “Follicular helper T cells are required for systemic autoimmunity,” Journal of Experimental Medicine, vol. 206, no. 3, pp. 561–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Ozaki, R. Spolski, R. Ettinger et al., “Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6,” The Journal of Immunology, vol. 173, no. 9, pp. 5361–5371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. J. A. Bubier, S. M. Bennett, T. J. Sproule et al., “Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus,” Annals of the New York Academy of Sciences, vol. 1110, pp. 590–601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Herber, T. P. Brown, S. Liang, D. A. Young, M. Collins, and K. Dunussi-Joannopoulos, “IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression,” The Journal of Immunology, vol. 178, no. 6, pp. 3822–3830, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. A. L. Rankin, H. Guay, D. Herber et al., “IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas lpr/lpr/J mice,” Journal of Immunology, vol. 188, no. 4, pp. 1656–1667, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. J. A. Bubier, T. J. Sproule, O. Foreman et al., “A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1518–1523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. J. M. Odegard, B. R. Marks, L. D. Diplacido et al., “ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity,” Journal of Experimental Medicine, vol. 205, no. 12, pp. 2873–2886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. J. William, C. Euler, S. Christensen, and M. J. Shlomchik, “Evolution of autoantibody responses via somatic hypermutation outside of germinal centers,” Science, vol. 297, no. 5589, pp. 2066–2070, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Simpson, P. A. Gatenby, A. Wilson et al., “Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 62, no. 1, pp. 234–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J.-Y. Choi, J. H.-E. Ho, S. G. Pasoto et al., “Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity,” Arthritis and Rheumatology, vol. 67, no. 4, pp. 988–999, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Feng, D. Wang, J. Chen et al., “Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus,” PLoS ONE, vol. 7, no. 12, Article ID e51982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. X. Zhang, E. Lindwall, C. Gauthier et al., “Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production,” Lupus, vol. 24, no. 9, pp. 909–917, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Xu, J. Liu, X. Cui et al., “Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner,” Cellular Immunology, vol. 295, no. 1, pp. 46–51, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Szabó, G. Papp, A. Szántó, T. Tarr, and M. Zeher, “A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 183, no. 1, pp. 76–89, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Morita, N. Schmitt, S.-E. Bentebibel et al., “Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion,” Immunity, vol. 34, no. 1, pp. 108–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. S. E. Bentebibel, S. Lopez, G. Obermoser et al., “Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination,” Science Translational Medicine, vol. 5, no. 7, Article ID 176ra32, 2013. View at Google Scholar
  67. J. He, L. M. Tsai, Y. Leong et al., “Circulating precursor CCR7loPD-1hi CXCR5+ CD4+ T cells indicate tfh cell activity and promote antibody responses upon antigen reexposure,” Immunity, vol. 39, no. 4, pp. 770–781, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Locci, C. Havenar-Daughton, E. Landais et al., “Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses,” Immunity, vol. 39, no. 4, pp. 758–769, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Le Coz, A. Joublin, J.-L. Pasquali, A.-S. Korganow, H. Dumortier, and F. Monneaux, “Circulating TFH subset distribution is strongly affected in lupus patients with an active disease,” PLoS ONE, vol. 8, no. 9, Article ID e75319, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. G. C. Zeller, J. Hirahashi, A. Schwarting, A. H. Sharpe, and V. R. Kelley, “Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus,” Journal of the American Society of Nephrology, vol. 17, no. 1, pp. 122–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. Y.-J. Liu, D. E. Joshua, G. T. Williams, C. A. Smith, J. Gordon, and I. C. M. MacLennan, “Mechanism of antigen-driven selection in germinal centres,” Nature, vol. 342, no. 6252, pp. 929–931, 1989. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Desai-Mehta, L. Lu, R. Ramsey-Goldman, and S. K. Datta, “Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production,” Journal of Clinical Investigation, vol. 97, no. 9, pp. 2063–2073, 1996. View at Publisher · View at Google Scholar · View at Scopus
  73. C. G. Katsiari, S.-N. C. Liossis, A. M. Dimopoulos, D. V. Charalambopoulos, M. Mavrikakis, and P. P. Sfikakis, “CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition,” Lupus, vol. 11, no. 6, pp. 370–378, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Zhou, J. Yuan, Y. Pan et al., “T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus,” Clinical Immunology, vol. 132, no. 3, pp. 362–370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Xu, X. Li, D. Liu et al., “Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility,” Nature, vol. 496, no. 7446, pp. 523–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. D. Liu, H. Xu, C. Shih et al., “T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction,” Nature, vol. 517, no. 7533, pp. 214–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. X.-N. Wu, Y.-X. Ye, J.-W. Niu et al., “Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus,” Science Translational Medicine, vol. 6, no. 246, Article ID 246ra99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. J.-H. Yang, J. Zhang, Q. Cai et al., “Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus,” Rheumatology, vol. 44, no. 10, pp. 1245–1254, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Hutloff, K. Büchner, K. Reiter et al., “Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 50, no. 10, pp. 3211–3220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. W.-X. Li, H.-F. Pan, G.-P. Chen, J.-H. Tao, X.-P. Li, and D.-Q. Ye, “Expression of inducible co-stimulator on peripheral blood T lymphocytes in patients with lupus nephritis,” Rheumatology International, vol. 32, no. 7, pp. 2051–2055, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Patschan, S. Dolff, A. Kribben et al., “CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus,” Clinical and Experimental Immunology, vol. 145, no. 2, pp. 235–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Aten, A. Roos, N. Claessen, E. J. M. Schilder-Tol, I. J. M. Ten Berge, and J. J. Weening, “Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis,” Journal of the American Society of Nephrology, vol. 11, no. 8, pp. 1426–1438, 2000. View at Google Scholar · View at Scopus
  83. D. S. C. Graham, R. R. Graham, H. Manku et al., “Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus,” Nature Genetics, vol. 40, no. 1, pp. 83–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. C. Jacquemin, N. Schmitt, C. Contin-Bordes et al., “OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response,” Immunity, vol. 42, no. 6, pp. 1159–1170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. H.-Y. Chun, J.-W. Chung, H.-A. Kim et al., “Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus,” Journal of Clinical Immunology, vol. 27, no. 5, pp. 461–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. G. Gröndal, I. Gunnarsson, J. Rönnelid, S. Rogberg, L. Klareskog, and I. Lundberg, “Cytokine production, serum levels and disease activity in systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 18, no. 5, pp. 565–570, 2000. View at Google Scholar · View at Scopus
  87. Y. Horii, M. Iwano, E. Hirata et al., “Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis,” Kidney International, vol. 39, pp. S71–S75, 1993. View at Google Scholar
  88. P. Esposito, M. M. Balletta, A. Procino, L. Postiglione, and B. Memoli, “Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis,” Lupus, vol. 18, no. 14, pp. 1329–1330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. M. De La Torre, J. M. Urra, and J. Blanco, “Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity?” Lupus, vol. 18, no. 3, pp. 216–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. X.-F. Wang, S.-L. Yuan, L. Jiang et al., “Changes of serum BAFF and IL-21 levels in patients with systemic lupus erythematosus and their clinical significance,” Xi Bao Yu Fen Mian Yi Xue Za Zhi, vol. 23, no. 11, pp. 1041–1042, 2007. View at Google Scholar · View at Scopus
  91. R. Caruso, E. Botti, M. Sarra et al., “Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis,” Nature Medicine, vol. 15, no. 9, pp. 1013–1015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Dolff, W. H. Abdulahad, J. Westra et al., “Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 13, no. 5, article R157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Webb, J. T. Merrill, J. A. Kelly et al., “A polymorphism within IL21R confers risk for systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 60, no. 8, pp. 2402–2407, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. A. H. Sawalha, K. M. Kaufman, J. A. Kelly et al., “Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 458–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Lan, B. Luo, J.-L. Wang, Y.-W. Jiang, and Y.-S. Wei, “The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus,” Gene, vol. 538, no. 1, pp. 94–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. J. Zhang, V. Roschke, K. P. Baker et al., “Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus,” The Journal of Immunology, vol. 166, no. 1, pp. 6–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. G. S. Cheema, V. Roschke, D. M. Hilbert, and W. Stohl, “Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases,” Arthritis and Rheumatism, vol. 44, no. 6, pp. 1313–1319, 2001. View at Google Scholar · View at Scopus
  98. W. Stohl, S. Metyas, S.-M. Tan et al., “B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations,” Arthritis & Rheumatism, vol. 48, no. 12, pp. 3475–3486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Petri, W. Stohl, W. Chatham et al., “Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 58, no. 8, pp. 2453–2459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Linker-Israeli, A. C. Bakke, R. C. Kitridou, S. Gendler, S. Gillis, and D. A. Horwitz, “Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE),” Journal of Immunology, vol. 130, no. 6, pp. 2651–2655, 1983. View at Google Scholar · View at Scopus
  101. L. A. Lieberman and G. C. Tsokos, “The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 740619, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. E. E. Solomou, Y.-T. Juang, M. F. Gourley, G. M. Kammer, and G. C. Tsokos, “Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus,” The Journal of Immunology, vol. 166, no. 6, pp. 4216–4222, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. T. Harada, V. Kyttaris, Y. Li, Y.-T. Juang, Y. Wang, and G. C. Tsokos, “Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration,” Autoimmunity, vol. 40, no. 1, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. C. M. Hedrich, T. Rauen, S. A. Apostolidis et al., “Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 37, pp. 13457–13462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. Tang, X. Luo, H. Cui et al., “MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins,” Arthritis and Rheumatism, vol. 60, no. 4, pp. 1065–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. J. B. Harley, M. E. Alarcón-Riquelme, L. A. Criswell et al., “Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci,” Nature Genetics, vol. 40, no. 2, pp. 204–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. S. E. Löfgren, J. Frostegård, L. Truedsson et al., “Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene,” Genes & Immunity, vol. 13, no. 3, pp. 268–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Miyara, Z. Amoura, C. Parizot et al., “Global natural regulatory T cell depletion in active systemic lupus erythematosus,” The Journal of Immunology, vol. 175, no. 12, pp. 8392–8400, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. M.-F. Liu, C.-R. Wang, L.-L. Fung, and C.-R. Wu, “Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus,” Scandinavian Journal of Immunology, vol. 59, no. 2, pp. 198–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. J. C. Crispin, A. Martínez, and J. Alcocer-Varela, “Quantification of regulatory T cells in patients with systemic lupus erythematosus,” Journal of Autoimmunity, vol. 21, no. 3, pp. 273–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Bonelli, A. Savitskaya, K. von Dalwigk et al., “Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE),” International Immunology, vol. 20, no. 7, pp. 861–868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. X. Valencia, C. Yarboro, G. Illei, and P. E. Lipsky, “Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus,” Journal of Immunology, vol. 178, no. 4, pp. 2579–2588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. R. K. C. Venigalla, T. Tretter, S. Krienke et al., “Reduced CD4+,CD25T cell sensitivity to the suppressive function of CD4+,CD25high,CD127/low regulatory T cells in patients with active systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 58, no. 7, pp. 2120–2130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. B. Yan, S. Ye, G. Chen, M. Kuang, N. Shen, and S. Chen, “Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α-producing antigen-presenting cells,” Arthritis & Rheumatism, vol. 58, no. 3, pp. 801–812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Iwai, M. Abe, S. Hirose et al., “Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis,” Journal of Immunology, vol. 171, no. 6, pp. 2848–2854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. Y.-L. Hu, D. P. Metz, J. Chung, G. Siu, and M. Zhang, “B7RP-1 blockade ameliorates autoimmunity through regulation of follicular helper T cells,” The Journal of Immunology, vol. 182, no. 3, pp. 1421–1428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. J. Ma, J. Xu, M. P. Madaio et al., “Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses,” Journal of Immunology, vol. 157, no. 1, pp. 417–426, 1996. View at Google Scholar · View at Scopus
  118. D. I. Daikh, B. K. Finck, P. S. Linsley, D. Hollenbaugh, and D. Wofsy, “Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways,” The Journal of Immunology, vol. 159, no. 7, pp. 3104–3108, 1997. View at Google Scholar · View at Scopus
  119. B. A. Kiberd, “Interleukin-6 receptor blockage ameliorates murine lupus nephritis,” Journal of the American Society of Nephrology, vol. 4, no. 1, pp. 58–61, 1993. View at Google Scholar · View at Scopus
  120. B. K. Finck, B. Chan, and D. Wofsy, “Interleukin 6 promotes murine lupus in NZB/NZW F1 mice,” Journal of Clinical Investigation, vol. 94, no. 2, pp. 585–591, 1994. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Mihara, N. Takagi, Y. Takeda, and Y. Ohsugi, “IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice,” Clinical and Experimental Immunology, vol. 112, no. 3, pp. 397–402, 1998. View at Publisher · View at Google Scholar · View at Scopus
  122. J. A. Gross, J. Johnston, S. Mudri et al., “TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease,” Nature, vol. 404, no. 6781, pp. 995–999, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. M. Ramanujam, R. Bethunaickan, W. Huang, H. Tao, M. P. Madaio, and A. Davidson, “Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice,” Arthritis and Rheumatism, vol. 62, no. 5, pp. 1457–1468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. Y. Vugmeyster, H. Guay, P. Szklut et al., “In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus,” mAbs, vol. 2, no. 3, pp. 335–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Zhang, G. Yu, B. Chan et al., “Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model,” Arthritis & Rheumatology, vol. 67, no. 10, pp. 2723–2731, 2015. View at Publisher · View at Google Scholar
  126. Y. Pan, T. Jia, Y. Zhang et al., “MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice,” International Journal of Nanomedicine, vol. 7, pp. 5957–5967, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. L. J. Edwards, M. Mizui, and V. Kyttaris, “Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice,” Clinical Immunology, vol. 158, no. 2, pp. 221–230, 2015. View at Publisher · View at Google Scholar · View at Scopus
  128. G. G. Illei, Y. Shirota, C. H. Yarboro et al., “Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study,” Arthritis and Rheumatism, vol. 62, no. 2, pp. 542–552, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. S. V. Navarra, R. M. Guzmán, A. E. Gallacher et al., “Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial,” The Lancet, vol. 377, no. 9767, pp. 721–731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Flynn, K.-M. Toellner, C. Raykundalia, M. Goodall, and P. Lane, “CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1,” The Journal of Experimental Medicine, vol. 188, no. 2, pp. 297–304, 1998. View at Publisher · View at Google Scholar · View at Scopus
  131. T. Brocker, A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane, “CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles,” European Journal of Immunology, vol. 29, no. 5, pp. 1610–1616, 1999. View at Google Scholar · View at Scopus
  132. M. Gigoux, J. Shang, Y. Pak et al., “Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 48, pp. 20371–20376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. C. S. Ma, N. Wong, G. Rao et al., “Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies,” Journal of Allergy and Clinical Immunology, vol. 136, no. 4, pp. 993–1006, 2015. View at Publisher · View at Google Scholar · View at Scopus
  134. D. Eto, C. Lao, D. DiToro et al., “IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation,” PLoS ONE, vol. 6, no. 3, Article ID e17739, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. N. M. Haynes, C. D. C. Allen, R. Lesley, K. M. Ansel, N. Killeen, and J. G. Cyster, “Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1High germinal center-associated subpopulation,” Journal of Immunology, vol. 179, no. 8, pp. 5099–5108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. D. Breitfeld, L. Ohl, E. Kremmer et al., “Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production,” The Journal of Experimental Medicine, vol. 192, no. 11, pp. 1545–1551, 2000. View at Publisher · View at Google Scholar · View at Scopus
  137. P. Schaerli, K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, and B. Moser, “CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function,” The Journal of Experimental Medicine, vol. 192, no. 11, pp. 1553–1562, 2000. View at Publisher · View at Google Scholar · View at Scopus
  138. T. M. Foy, J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle, “gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory,” The Journal of Experimental Medicine, vol. 180, no. 1, pp. 157–163, 1994. View at Publisher · View at Google Scholar · View at Scopus
  139. S. Salek-Ardakani, Y. S. Choi, M. R.-E. Benhnia et al., “B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus,” The Journal of Immunology, vol. 186, no. 9, pp. 5294–5303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. V. L. Bryant, C. S. Ma, D. T. Avery et al., “Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells,” Journal of Immunology, vol. 179, no. 12, pp. 8180–8190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. R. L. Reinhardt, H.-E. Liang, and R. M. Locksley, “Cytokine-secreting follicular T cells shape the antibody repertoire,” Nature Immunology, vol. 10, no. 4, pp. 385–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. I. Yusuf, R. Kageyama, L. Monticelli et al., “Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150),” Journal of Immunology, vol. 185, no. 1, pp. 190–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  143. K. L. Good-Jacobson, C. G. Szumilas, L. Chen, A. H. Sharpe, M. M. Tomayko, and M. J. Shlomchik, “PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells,” Nature Immunology, vol. 11, no. 6, pp. 535–542, 2010. View at Publisher · View at Google Scholar · View at Scopus